Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy

Yoon-Kee Siow1,2, Chin-Yu Lin1,3, Fa-Po Chung1,3

  • 1Heart Rhythm Center, Taipei Veterans General Hospital, Taipei, Taiwan.

PubMed

Insights

Catheter ablation offers long-term atrial fibrillation control in dilated cardiomyopathy patients, improving survival and heart function compared to medication alone. Left atrial diameter predicts recurrence after ablation.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Catheter ablation is effective for atrial fibrillation (AF).
  • Long-term outcomes of AF catheter ablation in dilated cardiomyopathy (DCM) are understudied.

Purpose of the Study:

  • Assess electrophysiological characteristics in AF patients with DCM.
  • Compare long-term clinical outcomes of catheter ablation versus medical therapy for AF in DCM.

Main Methods:

  • Examined baseline characteristics and electrophysiological parameters.
  • Identified predictors of AF recurrence post-ablation.
  • Used propensity score matching to compare outcomes of ablation and medical therapy.

Main Results:

  • 343 patients (46 ablation, 297 medical therapy).
  • AF recurrence rate was 30.4% after 7.7 years; left atrial diameter predicted recurrence.
  • Catheter ablation showed superior overall survival, reduced heart failure hospitalizations, and improved cardiac remodeling compared to medical therapy.

Conclusions:

  • Catheter ablation provides effective long-term AF control in DCM patients.
  • Ablation improves morbidity and mortality outcomes beyond standard heart failure care.
  • Catheter ablation reverses structural cardiac remodeling in DCM patients with AF.
Abstract